Effects of 5-aminolevulinic acid on the glutamatergic neurotransmission

Neurochemistry International

Volumn 42, Issue 2, 2003, Pages 115-121

  Emanuelli, Tatiana ^a,b   Pagel, Fernanda W ^b   Porciúncula, Lisiane O ^b   Souza, Diogo O ^b  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

5 Aminolevulinic acid; Astrocytes; Glutamate binding; Glutamate uptake; Lipoperoxidation; MK 801 binding

Indexed keywords

AMINOLEVULINIC ACID; DIZOCILPINE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BINDING AFFINITY; BRAIN CORTEX; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING; FEMALE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INHIBITION KINETICS; LIPID PEROXIDATION; NERVE CELL STIMULATION; NEUROTRANSMISSION; NEUROTRANSMITTER UPTAKE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINOLEVULINIC ACID; ANIMALS; ASTROCYTES; BUCLADESINE; CELLS, CULTURED; CEREBRAL CORTEX; DIZOCILPINE MALEATE; FEMALE; GLUTAMIC ACID; HUMANS; KINETICS; NERVE TISSUE PROTEINS; RATS; RATS, WISTAR; SYNAPTIC TRANSMISSION; TETRAZOLIUM SALTS; THIAZOLES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0037210054     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(02)00074-8     Document Type: Article

References (35)

1. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: review of properties, rfegulation and physiological functions. Glia. 32:2000;1-14.
2. Arriza J.L., Fairman W.A., Wadiche J.I., Murdoch G.H., Kavanaugh M.P., Amara S.G. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 14:1994;5559-5569.
3. Bonkowsky H.L., Sinclair P.R., Emery S., Sinclair J.F. Seizure management in acute hepatic porphyria: risks of valproate and clonazepan. Neurology. 30:1980;588-592.
4. Brennan M.J.W., Cantrill R.C. The effect of delta-aminolaevulinic acid on the uptake and efflux of amino acid neurotransmitters in rat brain synaptosomes. J. Neurochem. 33:1979a;721-725.
5. Brennan M.J.W., Cantrill R.C. Delta-aminolevulinic acid is a potent agonist for GABA autoreceptors. Nature (London). 280:1979;514-515.
6. Bylesjö I., Forsgren L., Lithner F., Boman K. Epidemiology and clinical characteristics of seizures in patients with acute intermittent porphyria. Epilepsia. 37:1996;230-235.
7. Chen Y., Ying W., Simma V., Copin J.C., Chan P.H., Swanson R.A. Overexpression of Cu, Zn superoxide dismutase attenuates oxidative inhibition of astrocyte glutamate uptake. J. Neurochem. 75:2000;939-945.
8. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65:2001;1-105.
9. De Matteis F., Zetterlund P., Wetterberg L. Brain 5-aminolaevulinate synthase. Biochem. J. 196:1981;811-817.
10. Demasi M., Penatti C.A.A., DeLucia R., Bechara E.J.H. The pro-oxidant effect of 5-aminolevulinic acid in the brain tissue of rats: implications in neuropsychiatric manifestations in porphyrias. Free Radic. Biol. Med. 20:1996;291-299.
11. 3H ]glutamate binding to fresh and frozen crude plasma membranes isolated from cerebral cortex of adult rats Biochem. Mol. Biol. Internat. 44:1998;1265-1272.
12. Emanuelli T., Prauchner C.A., Dacanal J., Zeni A., Reis E.C., Mello C.F., Souza D.O. Intrastriatal administration of 5-aminolevulinic acid induces convulsions and body asymmetry through glutamatergic mechanisms. Brain Res. 868:2000;88-94.
13. Emanuelli T., Pagel F.W., Alves L.B., Regner A., Souza D.O. Inhibition of adenylate cyclase activity by 5-aminolevulinic acid in rat and human brain. Neurochem. Int. 38:2001a;213-218.
14. 3H ]muscimol binding to human and rat brain synaptic membranes Neurochem. Res. 26:2001;101-105.
15. 2+ Eur. J. Pharmacol. 245:1993;233-239.
16. Jones D.H., Matus A.I. Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation. Biochim. Biophys. Acta. 356:1974;276-287.
17. Juknat A.A., Kotler M.L., Batlle A.M.C. High δ-aminolevulinic acid uptake in rat cerebral cortex: effect on pophyrin biosynthesis. Comp. Biochem. Physiol. 111C:1995;143-150.
18. Kappas, A., Sassa, S., Galbraith, R.A., Nordmann, Y., 1995. The porphyrias. In: Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D. (Eds.), The Metabolic Bases of Inherited Disease, 7th Edition. McGraw Hill, New York, pp. 2103-2160.
19. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
20. McLoughlin J.L., Cantrill R.C. The effect of delta-aminolaevulinic acid on the high affinity uptake of aspartic acid by rat brain synaptosomes. Gen. Pharmacol. 15:1984;553-555.
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival. J. Immunol. Methods. 65:1983;55-63.
22. Obrenovitch T.P., Urenjak J. Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy. Prog. Neurobiol. 51:1997;39-87.
23. Ozawa S., Kamiya H., Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog. Neurobiol. 54:1998;581-618.
24. 2+ uptake and mitochondrial permeabilization. Arch. Biochem. Biophys. 335:1996;53-60.
25. Pierach C.A., Edwards P.S. Neurotoxicity of δ-aminolevulinic acid and porphobilinogen. Exp. Neurol. 62:1978;810-814.
26. Porciúncula L.O., Rocha J.B.T., Boeck C.R., Vendite D., Souza D.O. Ebselen prevents excitotoxicity provoked by glutamate in rat cerebellar granule neurons. Neurosci. Lett. 299:2001;217-220.
27. Puy H., Deybach J.C., Bogdan A., Callebert J., Baumgartner M., Voisin P., Nordmann Y., Touitou Y. Increased δ-aminolevulinic acid and decreased pineal melatonin production: a common event in acute porphyria studies in the rat. J. Clin. Invest. 97:1996;104-110.
28. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 8:1996;1407-1415.
29. +-ATPase activity by δ-aminolevulinic acid. Neurochem. Res. 8:1983;1407-1415.
30. +-dependent glutamate transporters by cyclic AMP analogs and neurons. Mol. Pharmacol. 53:1998;355-369.
31. Shanley B.C., Neathling A.C., Percy V.A., Carstens M. Neurochemical aspects of porphyria: studies on the possible neurotoxicity of δ-aminolevulinic acid. S. Afr. J. Lab. Clin. Med. 49:1975;576-580.
32. Swanson R.A., Farrel K., Simon R.P. Acidosis and hypoxia cause astrocyte ATP depletion and failure of glutamate uptake. J. Cerebrovasc. Blood Flow Metab. 15:1995;417-424.
33. Swanson R.A., Liu J., Miller J.W., Rothstein J.D., Farrell K., Stein B.A., Longuemare M.C. Neuronal regulation of glutamate transporter subtype expression in astrocytes. J. Neurosci. 17:1997;932-940.
34. Trotti D., Rolfs A., Danbolt N.C., Brown R.H., Hediger M.A. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat. Neurosci. 2:1999;427-433.
35. Yeung Laiwah A.C., Moore M.R., Goldberg A. Pathogenesis of acute porphyria. Q. J. Med. 63:1987;377-392.